| Name | Title | Contact Details |
|---|
Interpore Cross is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bringing Together the Heart and Science of Medical Management Genex was founded in 1978 with the same directive it operates under today — helping injured workers return to their jobs in a safe and efficient manner through compassionate case management, thus reducing health care costs and disability expenses for our customers. Our medical and business professionals provide comprehensive care management and multicultural services from locations across the United States and Canada.
Biolux Research Ltd. is a world leader in the development of innovative Light Accelerated™ technology and products for use in orthodontics, implantology, and other dentistry markets.
American Clinical Research Services is a company that provides clinical research services.
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.